Objective
This study aims to identify consumer-level predictors of level of treatment response to Illness Management and Recovery (IMR) in order to target the appropriate consumers and aid psychiatric rehabilitation settings in developing intervention adaptations.
Methods
Secondary analyses from a multi-site study of IMR were conducted. Self-report data from consumer participants of the parent study (n = 236) were analyzed for the current study. Consumers completed pre-post surveys assessing illness management, coping, goal-related hope, social support, medication adherence, and working alliance. Correlations and multiple regression analyses were run in order to identify self-report variables that predicted level of treatment response to IMR.
Results
Analyses revealed that goal-related hope significantly predicted level of improved illness self-management, (F (1, 164) = 10.93, p <.001, R2 = .248, R2 Change = .05). Additionally, we found that higher levels of maladaptive coping at baseline were predictive of higher levels of adaptive coping at follow-up, (F (2, 180) = 5.29, p < .02, R2 = .38, R2 Change = .02). Evidence did not support additional predictors.
Conclusions and Implications for Practice
Previously, consumer-level predictors of level of treatment response have not been explored for IMR. Although two significant predictors were identified, study findings suggest more work is needed. Future research is needed to identify additional consumer-level factors predictive of IMR treatment response in order to identify who would benefit most from this treatment program.